Lifevantage (NASDAQ: LFVN) — Perfil da empresa, notícias e dados financeiros
Lifevantage develops dietary supplements and skincare products, emphasizing cellular health through innovative science.
Lifevantage
Lifevantage (NASDAQ:LFVN) delves into the development and sales of dietary supplements and skincare products through an innovative, science-based approach. Their operations span across multiple countries, focusing on enhancing health, vitality, and wellness globally. The company emphasizes research into nutrigenomics, aiming to improve cellular health through their product lineup, which includes Protandim®, a flagship supplement designed to combat oxidative stress, along with a range of skincare solutions under the TrueScience® brand. Lifevantage's objectives are centered on expanding their global reach, continuously innovating product offerings, and ultimately enhancing the overall well-being of their customers. Through direct selling and a strong community of distributors, they aim to deliver personal and financial empowerment, reflecting the company's commitment to fostering a better quality of life for individuals worldwide.
Resumo
Operações
Produtos e/ou serviços de Lifevantage
- Protandim, a dietary supplement aimed at reducing oxidative stress and improving health.
- TrueScience, a skincare line with anti-aging products designed to improve skin appearance and health.
- PhysIQ, a weight management system intended to support metabolism and weight loss.
- Petandim, a supplement designed to reduce oxidative stress in dogs, promoting their overall health.
- Axio, an energy drink developed to enhance focus, concentration, and energy without the typical crash.
- Hair Care System, a range of products focused on improving hair health and appearance.
equipe executiva do Lifevantage
- Carl A. AureChief Financial Officer
- Kristen CunninghamChief Sales Officer
- Terrence O. MooreheadPresident, CEO & Director
- Mike EdwardsChief Technology Officer
- Michelle Oborn-VirchowChief People Officer
Histórico de dividendos
Dividendos por ação pagos pela Lifevantage , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | — | — | — | $0.0500 |
| FY2026 | — | — | — | $0.1850 |
| FY2025 | — | — | — | $0.1650 |
| FY2024 | — | — | — | $0.5450 |
| FY2023 | — | — | — | $0.1250 |
Principais indicadores financeiros
Resultados divulgados pela Lifevantage , em USD.
- Cap. de mercado
- 74,2 mi
- Receita (TTM)
- 182,6 mi
- P/L
- 14.7
- LPA (diluído, TTM)
- 0.4
- Dividend yield
- 3.1%
- Margem de lucro
- 2.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 182,6 mi | 6,1 mi | 5,1 mi | |
| 228,5 mi | 12,2 mi | 9,8 mi | |
| 200,2 mi | 4,3 mi | 2,9 mi | |
| 213,4 mi | 4,3 mi | 2,5 mi |